CA2442742A1 - Quinazoline derivatives - Google Patents
Quinazoline derivatives Download PDFInfo
- Publication number
- CA2442742A1 CA2442742A1 CA002442742A CA2442742A CA2442742A1 CA 2442742 A1 CA2442742 A1 CA 2442742A1 CA 002442742 A CA002442742 A CA 002442742A CA 2442742 A CA2442742 A CA 2442742A CA 2442742 A1 CA2442742 A1 CA 2442742A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- hydrogen atom
- alkyl
- independently
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001045827 | 2001-02-21 | ||
| JP2001-45827 | 2001-02-21 | ||
| JP2001353525 | 2001-11-19 | ||
| JP2001-353525 | 2001-11-19 | ||
| PCT/JP2002/001575 WO2002066445A1 (en) | 2001-02-21 | 2002-02-21 | Quinazoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2442742A1 true CA2442742A1 (en) | 2002-08-29 |
Family
ID=26609852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002442742A Abandoned CA2442742A1 (en) | 2001-02-21 | 2002-02-21 | Quinazoline derivatives |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7294629B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1369418B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4285996B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR100861486B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1264824C (cg-RX-API-DMAC7.html) |
| AT (1) | ATE475652T1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2442742A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60237145D1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI309647B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002066445A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200813014A (en) * | 2002-03-28 | 2008-03-16 | Astrazeneca Ab | Quinazoline derivatives |
| US6924285B2 (en) | 2002-03-30 | 2005-08-02 | Boehringer Ingelheim Pharma Gmbh & Co. | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
| GB0309850D0 (en) | 2003-04-30 | 2003-06-04 | Astrazeneca Ab | Quinazoline derivatives |
| WO2005026150A1 (en) | 2003-09-16 | 2005-03-24 | Astrazeneca Ab | Quinazoline derivatives as tyrosine kinase inhibitors |
| DE602004004811T2 (de) * | 2003-09-19 | 2007-11-22 | Astrazeneca Ab | Chinazolinderivate |
| BRPI0414532B1 (pt) | 2003-09-19 | 2018-06-05 | Astrazeneca Ab | Composto derivado de quinazolina, processo para preparar 0 mesmo, composição farmaceutica, e, uso de um composto derivado de quinazolina |
| MXPA06003341A (es) * | 2003-09-25 | 2006-06-08 | Astrazeneca Ab | Derivados de quinazolina. |
| GB0322409D0 (en) | 2003-09-25 | 2003-10-29 | Astrazeneca Ab | Quinazoline derivatives |
| WO2005048953A2 (en) * | 2003-11-13 | 2005-06-02 | Ambit Biosciences Corporation | Amide derivatives as kinase modulators |
| GB0326459D0 (en) | 2003-11-13 | 2003-12-17 | Astrazeneca Ab | Quinazoline derivatives |
| US20070270589A1 (en) * | 2003-11-28 | 2007-11-22 | Mitsubishi Pharma Corporation | Quinazoline Derivative and Process for Producing the Same |
| ATE413389T1 (de) | 2004-02-03 | 2008-11-15 | Astrazeneca Ab | Chinazolinderivate |
| HRP20110958T1 (hr) | 2004-05-06 | 2012-01-31 | Warner-Lambert Company Llc | 4-fenilaminokinazolin-6-ilamidi |
| JPWO2006025490A1 (ja) * | 2004-09-01 | 2008-05-08 | 田辺三菱製薬株式会社 | 分子シャペロン機能調節剤 |
| ATE501148T1 (de) | 2004-12-14 | 2011-03-15 | Astrazeneca Ab | Pyrazolopyrimidinverbindungen als antitumormittel |
| AU2006216266C1 (en) * | 2005-02-23 | 2010-08-26 | Shionogi & Co., Ltd. | Quinazoline derivative having tyrosine kinase inhibitory activity |
| AU2006217738A1 (en) | 2005-02-26 | 2006-08-31 | Astrazeneca Ab | Quinazoline derivatives as tyrosine kinase inhibitors |
| WO2006106721A1 (ja) * | 2005-03-30 | 2006-10-12 | Shionogi & Co., Ltd. | チロシンキナーゼ阻害作用を有するピリミジン誘導体 |
| ES2354457T3 (es) | 2005-09-20 | 2011-03-15 | Astrazeneca Ab | Compuestos de 4-(1h-indazol-5-il-amino)-quinazolina como inhibidores del receptor erbb de la tirosina quinasa para el tratamiento del cáncer. |
| US20100048898A1 (en) * | 2006-03-03 | 2010-02-25 | Jacobsen Eric N | Process for Synthesizing 7-Alkynyl-4- Aminoquinazolines and a Related Intermediate |
| EP1921070A1 (de) | 2006-11-10 | 2008-05-14 | Boehringer Ingelheim Pharma GmbH & Co. KG | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung |
| JP5377332B2 (ja) | 2007-02-06 | 2013-12-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 二環式へテロ環、それらの化合物を含む薬剤、その使用及びその製法 |
| WO2009098061A1 (de) | 2008-02-07 | 2009-08-13 | Boehringer Ingelheim International Gmbh | Spirocyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
| MX2010012442A (es) | 2008-05-13 | 2011-10-11 | Astrazeneca Ab | Sal de fumarato de 4-(3-cloro-2-fluoroanilino)-7-metoxi-6-{[1-(n-m etilcarbamoilmetil) piperidin-4-il]oxi}quinazolina. |
| EP2313397B1 (de) | 2008-08-08 | 2016-04-20 | Boehringer Ingelheim International GmbH | Cyclohexyloxy-substituierte heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
| EP2547664B1 (de) * | 2010-03-16 | 2016-05-04 | Merck Patent GmbH | Morpholinylchinazoline |
| EP2680850B1 (en) * | 2011-03-04 | 2018-05-23 | Newgen Therapeutics, Inc. | Alkyne substituted quinazoline compound and methods of use |
| CN102918029B (zh) * | 2011-05-17 | 2015-06-17 | 江苏康缘药业股份有限公司 | 4-苯胺-6-丁烯酰胺-7-烷醚喹唑啉衍生物及其制备方法和用途 |
| US9464089B2 (en) | 2012-01-13 | 2016-10-11 | Acea Biosciences Inc. | Heterocyclic compounds and uses thereof |
| CA2861010A1 (en) | 2012-01-13 | 2013-07-18 | Xiao Xu | Heterocyclic compounds and uses as anticancer agents |
| US9034885B2 (en) | 2012-01-13 | 2015-05-19 | Acea Biosciences Inc. | EGFR modulators and uses thereof |
| US9586965B2 (en) | 2012-01-13 | 2017-03-07 | Acea Biosciences Inc. | Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases |
| CN103254143B (zh) * | 2013-04-26 | 2015-10-07 | 浙江工业大学 | 4-[4-(2-二乙氨基乙酰氨基)苯胺基]-6-取代喹唑啉类化合物及制备和应用 |
| CN104119350B (zh) | 2013-04-28 | 2017-04-12 | 广东东阳光药业有限公司 | 氨基喹唑啉类衍生物及其盐和使用方法 |
| BR112016000195A8 (pt) | 2013-07-11 | 2019-12-31 | Acea Biosciences Inc | compostos heterocíclicos, composição farmacêutica, combinação, seu uso, e método para inibir uma atividade da tirosina quinase btk ou jak, egfr, alk, pdgfr, blk, bmx/etk, flt3(d835y), itk, tec, txk, e suas respectivas vias |
| EP3359159B1 (en) | 2015-10-09 | 2023-06-07 | ACEA Therapeutics, Inc. | Pharmaceutical compositions of a pyrrolopyrimidine kinase inhibitor, and methods of making same |
| WO2018139626A1 (ja) * | 2017-01-30 | 2018-08-02 | 塩野義製薬株式会社 | キナゾリン誘導体を含有する固形製剤 |
| AU2017408099A1 (en) | 2017-04-07 | 2019-11-07 | ACEA Therapeutics, Inc. | Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same |
| WO2019233459A1 (zh) * | 2018-06-08 | 2019-12-12 | 江苏威凯尔医药科技有限公司 | 人表皮生长因子受体抑制剂及其制备方法和应用 |
| CN110577514B (zh) * | 2018-06-08 | 2022-07-05 | 江苏威凯尔医药科技有限公司 | 人表皮生长因子受体抑制剂及其制备方法和应用 |
| AU2020328598B2 (en) * | 2019-08-15 | 2026-07-02 | Black Diamond Therapeutics, Inc. | Alkynyl quinazoline compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3134236B2 (ja) | 1992-01-30 | 2001-02-13 | 株式会社林原生物化学研究所 | α−グリコシル−L−アスコルビン酸高含有物の製造方法とその製造のための分離システム |
| JP2994165B2 (ja) | 1992-06-26 | 1999-12-27 | ゼネカ・リミテッド | キナゾリン誘導体、その製造法および該キナゾリン誘導体を含有する抗癌作用を得るための医薬調剤 |
| CN100503580C (zh) | 1996-04-12 | 2009-06-24 | 沃尼尔·朗伯公司 | 酪氨酸激酶的不可逆抑制剂 |
| EP0837063A1 (en) | 1996-10-17 | 1998-04-22 | Pfizer Inc. | 4-Aminoquinazoline derivatives |
| ZA986732B (en) * | 1997-07-29 | 1999-02-02 | Warner Lambert Co | Irreversible inhibitiors of tyrosine kinases |
| US6251912B1 (en) * | 1997-08-01 | 2001-06-26 | American Cyanamid Company | Substituted quinazoline derivatives |
| CN1437594A (zh) * | 2000-06-22 | 2003-08-20 | 辉瑞产品公司 | 用于治疗异常细胞生长的取代的双环衍生物 |
| US20070270589A1 (en) * | 2003-11-28 | 2007-11-22 | Mitsubishi Pharma Corporation | Quinazoline Derivative and Process for Producing the Same |
-
2002
- 2002-02-21 JP JP2002565961A patent/JP4285996B2/ja not_active Expired - Fee Related
- 2002-02-21 TW TW091102988A patent/TWI309647B/zh active
- 2002-02-21 CA CA002442742A patent/CA2442742A1/en not_active Abandoned
- 2002-02-21 US US10/468,788 patent/US7294629B2/en not_active Expired - Fee Related
- 2002-02-21 CN CNB028052609A patent/CN1264824C/zh not_active Expired - Fee Related
- 2002-02-21 KR KR1020037011020A patent/KR100861486B1/ko not_active Expired - Fee Related
- 2002-02-21 EP EP02700688A patent/EP1369418B1/en not_active Expired - Lifetime
- 2002-02-21 WO PCT/JP2002/001575 patent/WO2002066445A1/ja not_active Ceased
- 2002-02-21 DE DE60237145T patent/DE60237145D1/de not_active Expired - Lifetime
- 2002-02-21 AT AT02700688T patent/ATE475652T1/de not_active IP Right Cessation
-
2007
- 2007-06-28 US US11/819,679 patent/US20070265260A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1369418A4 (en) | 2005-09-14 |
| US7294629B2 (en) | 2007-11-13 |
| TWI309647B (cg-RX-API-DMAC7.html) | 2009-05-11 |
| US20040116422A1 (en) | 2004-06-17 |
| JPWO2002066445A1 (ja) | 2004-06-17 |
| KR20030086269A (ko) | 2003-11-07 |
| EP1369418B1 (en) | 2010-07-28 |
| US20070265260A1 (en) | 2007-11-15 |
| DE60237145D1 (de) | 2010-09-09 |
| CN1264824C (zh) | 2006-07-19 |
| CN1492860A (zh) | 2004-04-28 |
| EP1369418A1 (en) | 2003-12-10 |
| JP4285996B2 (ja) | 2009-06-24 |
| KR100861486B1 (ko) | 2008-10-02 |
| WO2002066445A1 (en) | 2002-08-29 |
| ATE475652T1 (de) | 2010-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1369418B1 (en) | Quinazoline derivatives | |
| CA2218945C (en) | 4-aminoquinazoline derivatives | |
| US6225318B1 (en) | 4-aminoquinazolone derivatives | |
| JPWO2002066445A6 (ja) | キナゾリン誘導体 | |
| US6187786B1 (en) | Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles | |
| US6399615B1 (en) | Farnesyl protein transferase inhibitors | |
| JP4537582B2 (ja) | プロテインチロシンキナーゼインヒビターとしての置換3−シアノキノリン | |
| JP6457623B2 (ja) | 2,4−二置換7H−ピロロ[2,3−d]ピリミジン誘導体、その製造方法および医薬における使用 | |
| US6080769A (en) | Imidazolidin-4-one derivatives useful as anticancer agents | |
| CN102933578B (zh) | 氰基喹啉衍生物 | |
| ES2288615T3 (es) | Nuevos derivados de piridinamida y su uso. | |
| SK70498A3 (en) | Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2- -quinolinone derivatives | |
| NZ286263A (en) | 4 (substituted phenylamino) quinazoline derivatives, preparation and pharmaceutical compositions thereof | |
| BRPI0608160A2 (pt) | anticorpo isolado, célula hospedeira, método de inibir o crescimento de células psma+, e, uso de um anticorpo anti-psma defucosilado | |
| BRPI0610144A2 (pt) | método de preparar um 3-cianoquinolina substituìda; composto representado pela fórmula i; e composto, representado pela fórmula ii | |
| HUP0002954A2 (hu) | Farnezil-protein transzferáz új N-szubsztituált-karbamid inhibitorai | |
| JP2003528880A (ja) | 三環系タンパクキナーゼ阻害薬 | |
| EP1100788A1 (en) | Substituted quinazoline derivatives | |
| CN101638383B (zh) | 喹啉衍生物及其药物组合物和用途 | |
| CA2293358C (en) | Tricyclic sulfonamide inhibitors of farnesyl-protein transferase | |
| US6426352B1 (en) | Sulfonamide inhibitors of farnesyl-protein transferase | |
| NZ208056A (en) | Pyrimidine-thioalkyl-pyridines and pharmaceutical compositions | |
| CA2261724C (en) | Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase | |
| CN103554091B (zh) | 喹唑啉衍生物及其制备方法和用途 | |
| HUP0004806A2 (hu) | Farnezil-protein transzferáz gátlására alkalmazható benzo [5,6]ciklohepta[1,2-b]piridin-származékok és a vegyületeket tartalmazó gyógyszerkészítmények |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |